Title of article :
Pulmonary Manifestations of SARS-CoV-2 Infection in Mild/Severe Patients
Author/Authors :
Jalili ، Zahra Department of Medical Laser - Medical Laser Research Center, Yara Institute - Academic Center for Education, Culture and Research (ACECR) , Jalili ، Hamid Reza Department of Immunology and Hematology - Faculty of Medicine - Kurdistan University of Medical Sciences , Nazarinejad ، Nooshin Department of Microbiology - School of Medicine - Alborz University of Medical Sciences , Hajikhani ، Bahareh Department of Microbiology - School of Medicine - Shahid Beheshti University of Medical Sciences , Yazdani ، Shahrooz Department of Cardiology - School of Medicine - Alborz University of Medical Sciences , Bahonar ، Sara Department of Microbiology - School of Medicine - Shahid Beheshti University of Medical Sciences , Sameni ، Fatemeh Department of Microbiology - Faculty of Medicine - Shahed University
Abstract :
The coronavirus disease 2019 (COVID-19) caused viral pneumonia in Wuhan City in China in December of 2019. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily targets the lungs with severe hypoxia, which usually results in death. COVID-19 is highly heterogeneous regarding severity, clinical phenotype, and more importantly, global dispersal. The respiratory system in all aspects such as respiratory airways, endothelium of pulmonary vessels, conducting airways, the alveoli, neuromuscular breathing structure, and pulmonary circulation are affected by this virus. A comprehensive concept of the source and dynamic action of the SARS-CoV-2 and the possible causes of heterogeneity in COVID-19 is required for predicting and managing the illness in acute and chronic stages of the pulmonary sign.
Keywords :
COVID , 19 , SARS , CoV , 2 , Pulmonary manifestations , Lung involvement
Journal title :
Novelty in Biomedicine
Journal title :
Novelty in Biomedicine
